To facilitate biomedical research of illness mechanisms, a high-quality interactome that connects functionally associated genes is required to assist investigators formulate pathway hypotheses and to interpret the organic logic of a phenotype on the organic course of stage. Interactions within the up to date model of the human interactome useful resource (HIR V2) had been inferred from 36 mathematical characterizations of six sorts of knowledge that recommend purposeful associations between genes. This replace of the HIR consists of 88 069 pairs of genes (23.2% purposeful interactions of HIR V2 are in widespread with the earlier model of HIR), representing purposeful associations which might be of strengths just like these between well-studied protein interactions.
Amongst these purposeful interactions, 57% could symbolize protein interactions, that are anticipated to cowl 32% of the true human protein interactome. The gene set linkage evaluation (GSLA) device is developed primarily based on the high-quality HIR V2 to determine the potential purposeful impacts of the noticed transcriptomic modifications, serving to to elucidate their organic significance and complementing the at present extensively used enrichment-based gene set interpretation instruments. A case examine exhibits that the annotations reported by the HIR V2/GSLA system are extra complete and concise in comparison with these obtained by the extensively used gene set annotation instruments akin to PANTHER and DAVID.
Relationships Between Cardio Efficiency, Hemoglobin Ranges, and Coaching Load Throughout Small-Sided Video games: A Research in Skilled Soccer Gamers
The needs of this examine had been (1) to investigate between-session variations of exterior and inside load measures throughout small-sided video games (SSGs) and (2) to check the relationships between the utmost pace reached (VIFT) over the last stage of the 30-15 Intermittent Health Check, hemoglobin ranges, and coaching load measures throughout SSG intervals amongst skilled soccer gamers.
Sixteen skilled soccer gamers (imply ± SD; age 27.2 ± 3.Four years, peak 174.2 ± 3.6 cm, physique mass 69.1 ± 6.Four kg, and physique fats 10.4 ± 4.1%) participated on this examine. Hemoglobin and cardio efficiency had been first examined, after which a 3-week SSG program was utilized utilizing a Three vs. Three format. Throughout these Three weeks, inside and exterior load of complete classes had been additionally monitored for all coaching classes.
Trivial-to-small, standardized variations had been noticed between classes for exterior and inside measures throughout SSGs. Whole distance (TD) and mechanical work (MW) had been the one variables that indicated small modifications. Massive-to-very-large relationships had been discovered between VIFT and exterior masses: TD (r vary: 0.69; 0.87), high-intensity working (HIR; r vary: 0.66; 0.75), and MW (r vary: 0.56; 0.68).
Average-to-large adverse relationships had been discovered between hemoglobin ranges and inside masses: Edwards’ TRIMP (r vary: -0.36; -0.63), %HRmax (r vary: -0.50; -0.61), and purple zone (r vary: -0.50; -0.61). VIFT had unclear relationships with total inside masses, whereas hemoglobin ranges offered unclear relationships with total exterior masses.
In conclusion, no significant modifications had been discovered between classes contemplating the format of play used. Moreover, the detected relationships point out that VIFT and hemoglobin ranges are good indicators of the efficiency capability and physiological profile of gamers throughout SSGs. Additionally, the usage of SSGs protocols as a monitoring complement of the 30-15IFT is recommended.
A benzene-bridged divanadium complex-early transition metallic catalyst for alkene alkylarylation with PhI(O 2 CR) 2by way of decarboxylation
The synthesis, construction and catalytic exercise of a benzene-bridged divanadium advanced had been comprehensively studied. The discount of (Nacnac)VCl2 (1) (Nacnac = (2,6-iPr2C6H3NCMe)2HC) supported by β-diketiminate with potassium graphite (KC8) by using benzene because the solvent permits entry to the benzene-bridged inverted-sandwich divanadium advanced (μ-η6:η6-C6H6)[V(Nacnac)]2 (2a), which might catalyze alkene alkylarylation with hypervalent iodine(iii) reagents (HIRs) by way of decarboxylation to generate regioselectively various indolinones. Moreover, the gentle nature of this response was amenable to a variety of functionalities on alkenes and HIRs. Mechanistic research revealed a relay sequence of decarboxylative radical alkylation/radical arylation/oxidative re-aromatization.
Focusing on autophagy to modulate hepatic ischemia/reperfusion damage: A comparative examine between octreotide and melatonin as autophagy modulators by way of AMPK/PI3K/AKT/mTOR/ULK1 and Keap1/Nrf2 signaling pathways in rats
Hepatic ischemia-reperfusion (HIR) damage is a typical pathophysiological course of in lots of scientific settings. This examine was designed to check the protecting position of octreotide (somatostatin analogue, OCT) and melatonin (N-acetyl-5-methoxytryptamine, MLT) by way of the modulation of autophagy towards HIR damage in rats. Male albino rats had been divided into sham, HIR, OCT at three doses (50, 75, and 100 μg/kg), MLT, MLT+OCT75, compound C (AMPK inhibitor, CC), and CC+OCT75 teams. Ischemia was induced for 30 min adopted by 24 h reperfusion. Biochemical, histopathological, immunohistochemical, lipid peroxidation, ELISA, qPCR, and western blot methods had been carried out in our examine.
Liver autophagy was restored by OCT at doses (50 or 75 μg/kg) as indicated by elevating the expressions of Beclin-1, ATG7, and LC3 accompanied by the discount of p62 expression by way of induction of AMPK/S317-ULK1 and inhibition of PI3K/AKT/mTOR/S757-ULK1 signaling pathways. As nicely, OCT maintained the integrity of the Keap1-Nrf2 system for the traditional hepatic capabilities by way of controlling the Keap1 turnover by way of autophagy in a p62-dependent method, leading to upholding a sequence of anti-oxidant and anti inflammatory cascades.
Rat Anti-Mouse TIM-1 (CD365) Monoclonal antibody, clone 3B3 |
|||
| CABT-L4302-1mg | Creative Diagnostics | 1 mg | EUR 1076.4 |
Rat Anti-Mouse TIM-1 (CD365) Monoclonal antibody, clone 3B3 |
|||
| CABT-L4302-5mg | Creative Diagnostics | 5 mg | EUR 2886 |
HIRIP3 antibody |
|||
| 70R-2185 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal HIRIP3 antibody raised against the middle region of HIRIP3 |
|||
HIRIP3 antibody |
|||
| 70R-17741 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal HIRIP3 antibody |
|||
HIRIP3 Antibody |
|||
| 39461-100ul | SAB | 100ul | EUR 468 |
HIRIP3 antibody |
|||
| 31854-100ul | SAB | 100ul | EUR 302.4 |
HIRIP3 antibody |
|||
| 31854-50ul | SAB | 50ul | EUR 224.4 |
HIRIP3 antibody |
|||
| 10R-1507 | Fitzgerald | 100 ug | EUR 614.4 |
|
Description: Mouse monoclonal HIRIP3 antibody |
|||
HIRIP3 Antibody |
|||
| 1-CSB-PA010372GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against HIRIP3. Recognizes HIRIP3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
HIRIP3 Polyclonal Antibody |
|||
| 30792-100ul | SAB | 100ul | EUR 302.4 |
HIRIP3 Polyclonal Antibody |
|||
| 30792-50ul | SAB | 50ul | EUR 224.4 |
Polyclonal HIRIP3 Antibody |
|||
| APR02968G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIRIP3 . This antibody is tested and proven to work in the following applications: |
|||
Anti-HIRIP3 antibody |
|||
| PAab03871 | Lifescience Market | 100 ug | EUR 494.4 |
anti- HIRIP3 antibody |
|||
| FNab03871 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against HIRIP3 |
|||
Anti-HIRIP3 antibody |
|||
| STJ29094 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: The HIRA protein shares sequence similarity with Hir1p and Hir2p, the two corepressors of histone gene transcription characterized in the yeast, Saccharomyces cerevisiae. The structural features of the HIRA protein suggest that it may function as part of a multiprotein complex. Several cDNAs encoding HIRA-interacting proteins, or HIRIPs, have been identified. In vitro, the protein encoded by this gene binds HIRA, as well as H2B and H3 core histones, indicating that a complex containing HIRA-HIRIP3 could function in some aspects of chromatin and histone metabolism. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. |
|||
Mouse HIRIP3 shRNA Plasmid |
|||
| 20-abx982088 | Abbexa |
|
|
HIRIP3 Recombinant Protein (Mouse) |
|||
| RP141530 | ABM | 100 ug | Ask for price |
HIRIP3 siRNA |
|||
| 20-abx919397 | Abbexa |
|
|
HIRIP3 siRNA |
|||
| 20-abx919398 | Abbexa |
|
|
anti-HIRIP3 |
|||
| YF-PA15655 | Abfrontier | 50 ul | EUR 435.6 |
|
Description: Mouse polyclonal to HIRIP3 |
|||
anti-HIRIP3 |
|||
| YF-PA15656 | Abfrontier | 50 ug | EUR 435.6 |
|
Description: Mouse polyclonal to HIRIP3 |
|||
pOTB7-HIRIP3 |
|||
| PVT18716 | Lifescience Market | 2 ug | EUR 277.2 |
Anti-ASFV P72 Antibody | MASF-5A-Clone #10E11 |
|||
| MASF-5A-Clone-10E11 | Immunology Consultants Laboratory | 1 mg | EUR 667 |
|
Description: Anti-ASFV P72 Antibody | MASF-5A-Clone #10E11 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-ASFV P72 Antibody | MASF-5A-Clone #10G5 |
|||
| MASF-5A-Clone-10G5 | Immunology Consultants Laboratory | 1 mg | EUR 667 |
|
Description: Anti-ASFV P72 Antibody | MASF-5A-Clone #10G5 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Polyclonal HIRIP3 Antibody (Center) |
|||
| APR16639G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIRIP3 (Center). This antibody is tested and proven to work in the following applications: |
|||
HIRIP3 Polyclonal Conjugated Antibody |
|||
| C30792 | SAB | 100ul | EUR 476.4 |
HIRIP3 Polyclonal Conjugated Antibody |
|||
| C31854 | SAB | 100ul | EUR 476.4 |
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#3B11 |
|||
| MALV-30A-Clone-3B11 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#3B11 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#5A4 |
|||
| MALV-30A-Clone-5A4 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#5A4 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6C2 |
|||
| MALV-30A-Clone-6C2 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6C2 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6D7 |
|||
| MALV-30A-Clone-6D7 | Immunology Consultants Laboratory | 1.0 mg | EUR 448 |
|
Description: Anti-Avian Leukosis Virus Antibody | MALV-30A-Clone#6D7 | Immunology Consultants Laboratory Host: Mouse Format: Unconjugated AP Product Type: Primary Antibody Antibody Clonality: Monoclonal |
|||
Monoclonal Ku (p70/p80)Mouse Monoclonal Antibody [Clone KU729], Clone: KU729 |
|||
| AMM00210G | Leading Biology | 0.5ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Ku (p70/p80)Mouse Monoclonal [Clone KU729]. The antibodies are raised in Mouse and are from clone KU729. This antibody is applicable in IF, FC |
|||
Monoclonal Mouse Bmi1 Antibody, Clone: 353CT22.4.4 |
|||
| AMM02383G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human Mouse Bmi1. The antibodies are raised in Mouse and are from clone 353CT22.4.4. This antibody is applicable in WB, E |
|||
Monoclonal mouse Splunc2 Antibody, Clone: 1F12 |
|||
| APR07136G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human mouse Splunc2. The antibodies are raised in Mouse and are from clone 1F12. This antibody is applicable in WB and IHC, FC, ICC, E |
|||
Monoclonal mouse Lplunc1 Antibody, Clone: 4H2 |
|||
| APR08492G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human mouse Lplunc1. The antibodies are raised in Mouse and are from clone 4H2. This antibody is applicable in WB and IHC, FC, ICC, E |
|||
Monoclonal mouse Lplunc1 Antibody, Clone: 1F11E3 |
|||
| APR08493G | Leading Biology | 0.1ml | EUR 633.6 |
|
Description: A Monoclonal antibody against Human mouse Lplunc1. The antibodies are raised in Mouse and are from clone 1F11E3. This antibody is applicable in WB, E |
|||
Hirip3 ORF Vector (Mouse) (pORF) |
|||
| ORF047178 | ABM | 1.0 ug DNA | EUR 607.2 |
Monoclonal NGFR Antibody (Clone # 8G3G10), Clone: Clone # 8G3G10 |
|||
| AMM06686G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human NGFR (Clone # 8G3G10). The antibodies are raised in Mouse and are from clone Clone # 8G3G10. This antibody is applicable in WB and IF, FC |
|||
Monoclonal S100A8 Antibody (Clone IMG48M7C7), Clone: Clone IMG48M7C7 |
|||
| AMM00015G | Leading Biology | 0.1mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human S100A8 (Clone IMG48M7C7). The antibodies are raised in Mouse and are from clone Clone IMG48M7C7. This antibody is applicable in WB and IHC |
|||
Monoclonal PDGFR Antibody (Clone # 275CT1), Clone: Clone # 275CT1 |
|||
| AMM00020G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human PDGFR (Clone # 275CT1). The antibodies are raised in Mouse and are from clone Clone # 275CT1. This antibody is applicable in WB |
|||
anti-RAB7B (3B3) |
|||
| LF-MA10271 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to RAB7B |
|||
Anti-Glyt2 (3B3) |
|||
| YF-MA16694 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to Glyt2 |
|||
Anti-RAX (3B3) |
|||
| YF-MA18303 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to RAX |
|||
Anti-HES2 (3B3) |
|||
| YF-MA18677 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to HES2 |
|||
Anti-CTNNBIP1 (3B3) |
|||
| YF-MA19005 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to CTNNBIP1 |
|||
Anti-CABP4 (3B3) |
|||
| YF-MA19007 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to CABP4 |
|||
Anti-MTA3 (3B3) |
|||
| YF-MA19060 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to MTA3 |
|||
Anti-BPOZ (3B3) |
|||
| YF-MA19413 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to BPOZ |
|||
Anti-Olig1 (3B3) |
|||
| YF-MA19770 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to Olig1 |
|||
Anti-SERPINA12 (3B3) |
|||
| YF-MA19907 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to SERPINA12 |
|||
Anti-STK32A (3B3) |
|||
| YF-MA20023 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to STK32A |
|||
Anti-JNK1 (3B3) |
|||
| YF-MA14907 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to JNK1 |
|||
Anti-Peripherin (3B3) |
|||
| YF-MA14965 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to Peripherin |
|||
Anti-synaptophysin (3B3) |
|||
| YF-MA15691 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to synaptophysin |
|||
Anti-LIPF (3B3) |
|||
| YF-MA16392 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to LIPF |
|||
Anti-HEY1 (3B3) |
|||
| YF-MA11407 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to HEY1 |
|||
Anti-ALDOB (3B3) |
|||
| YF-MA11897 | Abfrontier | 100 ug | EUR 435.6 |
|
Description: Mouse monoclonal to ALDOB |
|||
Monoclonal CD11c FITC Monoclonal Antibody (Clone 3.9), Clone: 3.9 |
|||
| APR15331G | Leading Biology | 50 tests | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD11c FITC Monoclonal (Clone 3.9). The antibodies are raised in Mouse and are from clone 3.9. This antibody is applicable in FC |
|||
Monoclonal CD28 FITC Monoclonal Antibody (Clone CD28.2), Clone: CD28.2 |
|||
| AMM00025G | Leading Biology | 0.05mg | EUR 475.2 |
|
Description: A Monoclonal antibody against Human CD28 FITC Monoclonal (Clone CD28.2). The antibodies are raised in Mouse and are from clone CD28.2. This antibody is applicable in FC |
|||
HIRIP3 Blocking Peptide |
|||
| 33R-8235 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HIRIP3 antibody, catalog no. 70R-2185 |
|||
HIRIP3 Rabbit pAb |
|||
| A7014-100ul | Abclonal | 100 ul | EUR 369.6 |
HIRIP3 Rabbit pAb |
|||
| A7014-200ul | Abclonal | 200 ul | EUR 550.8 |
HIRIP3 Rabbit pAb |
|||
| A7014-20ul | Abclonal | 20 ul | EUR 219.6 |
HIRIP3 Rabbit pAb |
|||
| A7014-50ul | Abclonal | 50 ul | EUR 267.6 |
HIRIP3 cloning plasmid |
|||
| CSB-CL883612HU-10ug | Cusabio | 10ug | EUR 451.2 |
|
Description: A cloning plasmid for the HIRIP3 gene. |
|||
Monoclonal TNFSF18 Antibody (monoclonal), Clone: 2E11 |
|||
| AMM04221G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human TNFSF18 (monoclonal). The antibodies are raised in mouse and are from clone 2E11. This antibody is applicable in WB, E |
|||
Monoclonal FTL Antibody (monoclonal), Clone: 4G7 |
|||
| AMM04622G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human FTL (monoclonal). The antibodies are raised in Mouse and are from clone 4G7. This antibody is applicable in WB, E |
|||
Monoclonal CST3 Antibody (monoclonal), Clone: 1H4 |
|||
| AMM03425G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CST3 (monoclonal). The antibodies are raised in Mouse and are from clone 1H4. This antibody is applicable in WB |
|||
Monoclonal ERP44 Antibody (clone 3C7), Clone: 3C7 |
|||
| AMM04437G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human ERP44 (clone 3C7). The antibodies are raised in Mouse and are from clone 3C7. This antibody is applicable in WB and IHC-P, E, IP |
|||
Monoclonal FADS1 Antibody (clone 2D9), Clone: 2D9 |
|||
| AMM04499G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human FADS1 (clone 2D9). The antibodies are raised in Mouse and are from clone 2D9. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal FOXA2 Antibody (clone 1C7), Clone: 1C7 |
|||
| AMM04590G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human FOXA2 (clone 1C7). The antibodies are raised in Mouse and are from clone 1C7. This antibody is applicable in WB and IHC-P, IF, E, IP |
|||
Monoclonal G6PD Antibody (clone AT2F6), Clone: AT2F6 |
|||
| AMM04645G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human G6PD (clone AT2F6). The antibodies are raised in Mouse and are from clone AT2F6. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal GALT Antibody (clone 4C11), Clone: 4C11 |
|||
| AMM04683G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human GALT (clone 4C11). The antibodies are raised in Mouse and are from clone 4C11. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal GAPDH Antibody (clone 1D4), Clone: 1D4 |
|||
| AMM04700G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GAPDH (clone 1D4). The antibodies are raised in Mouse and are from clone 1D4. This antibody is applicable in WB and IHC-P, IF |
|||
Monoclonal GAPDH Antibody (clone 4G5), Clone: 4G5 |
|||
| AMM04701G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GAPDH (clone 4G5). The antibodies are raised in Mouse and are from clone 4G5. This antibody is applicable in WB and IHC-P, IF, E, IP, IHC-Fr |
|||
Monoclonal GAPDH Antibody (clone 4G5), Clone: 4G5 |
|||
| AMM04702G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GAPDH (clone 4G5). The antibodies are raised in Mouse and are from clone 4G5. This antibody is applicable in WB and IHC-P, IF, E, IP |
|||
Monoclonal GAPDH Antibody (clone 6C5), Clone: 6C5 |
|||
| AMM04703G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GAPDH (clone 6C5). The antibodies are raised in Mouse and are from clone 6C5. This antibody is applicable in WB and IHC-P, IF, E, IP, IHC-Fr |
|||
Monoclonal GAPDH Antibody (clone B903M), Clone: B903M |
|||
| AMM04704G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GAPDH (clone B903M). The antibodies are raised in Mouse and are from clone B903M. This antibody is applicable in WB and IHC-P, ICC, E |
|||
Monoclonal GOT2 Antibody (clone 3E9), Clone: 3E9 |
|||
| AMM05170G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GOT2 (clone 3E9). The antibodies are raised in Mouse and are from clone 3E9. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal GPI Antibody (clone 1B7D7), Clone: 1B7D7 |
|||
| AMM05182G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GPI (clone 1B7D7). The antibodies are raised in Mouse and are from clone 1B7D7. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal GPI Antibody (clone 4B11), Clone: 4B11 |
|||
| AMM05183G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GPI (clone 4B11). The antibodies are raised in Mouse and are from clone 4B11. This antibody is applicable in WB and IHC-P, IF |
|||
Monoclonal GPX7 Antibody (clone 2704), Clone: 2704 |
|||
| AMM05213G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human GPX7 (clone 2704). The antibodies are raised in Mouse and are from clone 2704. This antibody is applicable in WB and IHC-P |
|||
Monoclonal GSTA1 Antibody (clone 2F7), Clone: 2F7 |
|||
| AMM05231G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human GSTA1 (clone 2F7). The antibodies are raised in Mouse and are from clone 2F7. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal GSTA3 Antibody (clone 1F11), Clone: 1F11 |
|||
| AMM05234G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human GSTA3 (clone 1F11). The antibodies are raised in Mouse and are from clone 1F11. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal GSTM2 Antibody (clone 1E10), Clone: 1E10 |
|||
| AMM05250G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human GSTM2 (clone 1E10). The antibodies are raised in Mouse and are from clone 1E10. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal HDAC3 Antibody (clone 7G6C5), Clone: 7G6C5 |
|||
| AMM05320G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human HDAC3 (clone 7G6C5). The antibodies are raised in Mouse and are from clone 7G6C5. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal CD80 Antibody (clone 2A2), Clone: 2A2 |
|||
| AMM05353G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD80 (clone 2A2). The antibodies are raised in Mouse and are from clone 2A2. This antibody is applicable in IHC-P, IF, E |
|||
Monoclonal CD86 Antibody [Clone BU63], Clone: BU63 |
|||
| AMM05354G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD86 [Clone BU63]. The antibodies are raised in Mouse and are from clone BU63. This antibody is applicable in WB, IP |
|||
Monoclonal CD86 Antibody [Clone BU63], Clone: BU63 |
|||
| AMM05355G | Leading Biology | 0.1mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD86 [Clone BU63]. The antibodies are raised in Mouse and are from clone BU63. This antibody is applicable in FC |
|||
Monoclonal TSG101 Antibody (clone 5B7), Clone: 5B7 |
|||
| AMM05442G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human TSG101 (clone 5B7). The antibodies are raised in Mouse and are from clone 5B7. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal CACNA2D2 Antibody (clone 3A4), Clone: 3A4 |
|||
| AMM05669G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human CACNA2D2 (clone 3A4). The antibodies are raised in Mouse and are from clone 3A4. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal CRYM Antibody (clone 1G7), Clone: 1G7 |
|||
| AMM05810G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CRYM (clone 1G7). The antibodies are raised in Mouse and are from clone 1G7. This antibody is applicable in WB and IHC-P, IF, Flo |
|||
Monoclonal CRYM Antibody (clone 6B3), Clone: 6B3 |
|||
| AMM05811G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human CRYM (clone 6B3). The antibodies are raised in Mouse and are from clone 6B3. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal LCN1 Antibody (clone 10B10), Clone: 10B10 |
|||
| AMM06240G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A Monoclonal antibody against Human LCN1 (clone 10B10). The antibodies are raised in Mouse and are from clone 10B10. This antibody is applicable in WB and IHC-P, IF, E |
|||
Monoclonal LHX1 Antibody (clone 2G10), Clone: 2G10 |
|||
| AMM06281G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human LHX1 (clone 2G10). The antibodies are raised in Mouse and are from clone 2G10. This antibody is applicable in IHC-P, E |
|||
Monoclonal LHX4 Antibody (clone 1D6), Clone: 1D6 |
|||
| AMM06286G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human LHX4 (clone 1D6). The antibodies are raised in Mouse and are from clone 1D6. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal MECP2 Antibody (clone 4B6), Clone: 4B6 |
|||
| AMM06349G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human MECP2 (clone 4B6). The antibodies are raised in Mouse and are from clone 4B6. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal NDRG4 Antibody (clone 2G3), Clone: 2G3 |
|||
| AMM06585G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human NDRG4 (clone 2G3). The antibodies are raised in Mouse and are from clone 2G3. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal Neuroserpin Antibody (clone 1D10), Clone: 1D10 |
|||
| AMM06649G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human Neuroserpin (clone 1D10). The antibodies are raised in Mouse and are from clone 1D10. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal NR1D1 Antibody (clone 4F6), Clone: 4F6 |
|||
| AMM06804G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human NR1D1 (clone 4F6). The antibodies are raised in Mouse and are from clone 4F6. This antibody is applicable in WB and IHC-P, IF, E, RNAi |
|||
Monoclonal OLIG2 Antibody (clone 3C9), Clone: 3C9 |
|||
| AMM06897G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human OLIG2 (clone 3C9). The antibodies are raised in Mouse and are from clone 3C9. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal EDEM2 Antibody (clone 2E4), Clone: 2E4 |
|||
| AMM07004G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human EDEM2 (clone 2E4). The antibodies are raised in Mouse and are from clone 2E4. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal PDE9A Antibody (clone 1E1), Clone: 1E1 |
|||
| AMM07065G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PDE9A (clone 1E1). The antibodies are raised in Mouse and are from clone 1E1. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal PGRMC2 Antibody (clone 3C11), Clone: 3C11 |
|||
| AMM07132G | Leading Biology | 0.05mg | EUR 633.6 |
|
Description: A Monoclonal antibody against Human PGRMC2 (clone 3C11). The antibodies are raised in Mouse and are from clone 3C11. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal CD59 Antibody (clone 1F5), Clone: 1F5 |
|||
| AMM01702G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD59 (clone 1F5). The antibodies are raised in Mouse and are from clone 1F5. This antibody is applicable in IHC-P, Flo |
|||
Monoclonal TIMP2 Antibody (clone F27P3A4), Clone: F27P3A4 |
|||
| AMM01705G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human TIMP2 (clone F27P3A4). The antibodies are raised in Mouse and are from clone F27P3A4. This antibody is applicable in WB and IHC-P, E |
|||
Monoclonal NFKB1 Antibody (clone 4D1), Clone: 4D1 |
|||
| AMM01706G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human NFKB1 (clone 4D1). The antibodies are raised in Mouse and are from clone 4D1. This antibody is applicable in WB and IHC-P, IF |
|||
Monoclonal CD74 Antibody (clone LN2), Clone: LN2 |
|||
| AMM01728G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD74 (clone LN2). The antibodies are raised in Mouse and are from clone LN2. This antibody is applicable in IHC-P, IP, Flo |
|||
Monoclonal TPX2 Antibody (clone 18D5), Clone: 18D5 |
|||
| AMM01736G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human TPX2 (clone 18D5). The antibodies are raised in Mouse and are from clone 18D5. This antibody is applicable in WB and IHC-P |
|||
Monoclonal B3GAT1 Antibody (clone HCD57), Clone: HCD57 |
|||
| AMM01737G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human B3GAT1 (clone HCD57). The antibodies are raised in Mouse and are from clone HCD57. This antibody is applicable in IHC-P, Flo |
|||
Monoclonal CD74 Antibody (clone LN2), Clone: LN2 |
|||
| AMM01741G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A Monoclonal antibody against Human CD74 (clone LN2). The antibodies are raised in Mouse and are from clone LN2. This antibody is applicable in IHC-P, IP, IHC-Fr, Flo |
|||
These results had been abolished by compound C. However, MLT confirmed a lower within the autophagy markers by way of inhibiting AMPK/pS317-ULK1 and activating PI3K/AKT/mTOR/pS757-ULK1 pathways. Autophagy inhibition with MLT markedly reversed the hepatoprotective results of OCT75 after HIR damage. Lastly, our outcomes proved for the primary time that OCT75 was more practical than MLT because it was ample to induce protecting autophagy in our HIR mannequin, which led to the induction of Nrf2-dependent AMPK/autophagy pathways.